Snyder, Jami. – 2021
This annual report provides program information on Arizona drug abuse treatment programs that received State funding for State Fiscal Year (SFY) 2020 (July 2019 through June 2020). It begins by reviewing legislation that included several key initiatives to combat the opioid epidemic in Arizona and led to increased funding for treatment programs, as well as federal grants that increased funding. The report then provides information on the location of substance use disorder treatment programs, overall program funding, enrolled and served demographics, substance use disorders addressed by the programs, the eight major categories of services provided, and medication assisted treatment services. Data indicates: during SFY 2020, the Arizona Health Care Cost Containment System (AHCCCS) expended over $529 million in service funding for members and families with substance abuse disorder (SUD); the single largest source of SUD treatment funding was Medicaid, followed by Federal Substance Abuse Block Grant funds; the majority (53%) of members who were enrolled and received a SUD treatment service in SFY 2020 were White; the vast majority of members with a SUD and served in SFY 2020 were adults, with those between the ages of 25 and 44 accounting for more than half of all members (51%); hallucinogens were the most common substance used statewide by those in treatment in 2020 at 37%, followed closely by opiates at 27%; from July 1, 2019 through June 30, 2020, AHCCCS grant funding enabled local entities to distribute 123,207 doses of Naloxone throughout Arizona; and the Substance Use Disorder Services fund appropriation has supplied 51,907 services to 32,555 under and uninsured distinct, unduplicated individuals with opioid use disorder in Arizona between February 1, 2018 and September 29, 2020. The report closes with a chart that lists substance abuse disorder programs in Arizona and their address.